NEW YORK, November 2, 2016 /PRNewswire/ --
Stock-Callers.com has lined up the following Personal Products equities for evaluation: The Procter & Gamble Co. (NYSE: PG), Avon Products Inc. (NYSE: AVP), Colgate-Palmolive Co. (NYSE: CL), and Herbalife Ltd (NYSE: HLF). According to a new report by Grand View Research, Inc., the global personal care specialty ingredients market is expected to reach $15.76 billion by 2024 due to rising consumer awareness towards hygiene, and increasing disposable income in emerging economies. Learn more about these stocks by downloading their free research reports in PDF format at:
Procter & Gamble
Ohio-based The Procter & Gamble Co.'s shares rose 0.06% and finished Tuesday's trading session at $86.85. A total volume of 8.56 million shares was traded. In the previous three months and since the start of this year, the stock has advanced 1.80% and 12.96%, respectively. The Company's shares are trading above their 200-day moving average by 4.94%. Moreover, shares of P&G, which provides branded consumer packaged goods to consumers in North America, Europe, the Asia Pacific, India, the Middle East, Africa, and Latin America, have a Relative Strength Index (RSI) of 49.43.
On October 26th, 2016, research firm B. Riley & Co. reiterated its 'Buy' rating on the Company's stock with an increase of the target price from $105 a share to $106 a share.
On October 31st, 2016, P&G filed a lawsuit in the U.S. District Court for the Middle District of Tennessee against Vi-Jon, Inc., a manufacturer of personal care products. The lawsuit focuses on Vi-Jon's store brand dandruff shampoos, which are sold in major retail outlets throughout the U.S. The complaint alleges that Vi-Jon bottles sold in Dollar General, CVS and Kroger mimic the shape, colors and label of Head & Shoulders, the leader of the dandruff category and the world's #1 shampoo, in a way that infringes its trade dress. Sign up and read the free research report on PG at:
On Tuesday, shares in New York headquartered Avon Products Inc. recorded a trading volume of 6.31 million shares, which was above their three months average volume of 5.56 million shares. The stock ended the session 2.44% lower at $6.39. The Company's shares have gained 13.30% in the last one month, 25.79% over the previous three months, and 57.78% on an YTD basis. The stock is trading 7.91% above its 50-day moving average and 39.52% above its 200-day moving average. Furthermore, shares of Avon Products, which manufactures and markets beauty and related products worldwide, have an RSI of 51.79.
On October 07th, 2016, Avon announced that it will provide a live webcast of its Q3 2016 earnings conference call on November 3rd, 2016, at 9:00 a.m. ET. The complimentary research report on AVP can be downloaded at:
Shares in New York headquartered Colgate-Palmolive Co. closed the day at $70.99, slightly down 0.52%. The stock recorded a trading volume of 2.33 million shares. The Company's shares have gained 8.96% on an YTD basis, and are trading 0.85% above their 200-day moving average. Additionally, shares of Colgate-Palmolive, which together with its subsidiaries, manufactures and sells consumer products worldwide, have an RSI of 39.89.
On October 27th, 2016, Colgate-Palmolive reported worldwide net sales of $3,867 million in Q3 2016, a decrease of 3.5% versus Q3 2015. Global unit volume decreased 4.0%, pricing increased 3.0% and foreign exchange was negative 2.5% as compared to Q3 2015. Net income and diluted earnings per share (EPS) in Q3 2016 were $702 million and $0.78, respectively, compared to net income and diluted EPS of $726 million and $0.80, respectively, in Q3 2015.
On October 28th, 2016, research firm UBS reiterated its 'Neutral' rating on the Company's stock with a decrease of the target price from $78 a share to $76 a share. Register for free on Stock-Callers.com and access the latest report on CL at:
At the closing bell yesterday, shares in the Cayman Islands-based Herbalife Ltd ended 2.57% lower at $59.12. A total volume of 1.86 million shares was traded, which was above their three months average volume of 1.33 million shares. The stock has advanced 10.26% since the start of this year. The Company's shares are trading above their 200-day moving average by 0.11%. Furthermore, shares of Herbalife, which develops and sells weight management, healthy meals and snacks, sports and fitness, energy and targeted nutritional products, and personal care products, have an RSI of 35.94.
On November 01st, 2016, Herbalife reported Q3 2016 volume growth of 6% and net sales of $1.1 billion, reflecting an increase of 2%, each, compared to Q3 2015. On a reported basis, Q3 2016 net income was $87.7 million, or $1.01 per diluted share, compared to net income of $93.6 million, or $1.09 per diluted share, for Q3 2015. Get free access to your research report on HLF at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email email@example.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: +44 330 808 3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA